Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Production and inequality wreck biotech adoption

Bellasio et al., 21 (Jacopo Bellasio, Linda Slapakova, Luke Huxtable, James Black, Theodora Ogden and Livia Dawaele, RAND Europe, 7-2021, " Innovative technologies shaping the 2040 battlefield," STOA | Panel for the Future of Science and Technology, https://www.europarl.europa.eu/RegData/etudes/STUD/2021/690038/EPRS_STU(2021)690038_EN.pdf, LASA-CSK)

Existing literature documents significant concerns that many emerging biotechnologies are susceptible to single points of failure for essential components. 144 For example, while the bioengineering of silkworms to generate 'dragon silk' could produce advanced body armour, silkworms survive on mulberry leaves, and would require over 6,000 acres of mulberry trees for large-scale production. Current examples of such production processes, such as those pursued by the US Department of Defence (DOD), highlight the reliance of the production process on farming cooperatives in Vietnam, which require international contracts, embassy approvals and a complex supply chain, representing a potential singlesource point of failure. 145 Inequality of access represents a further potential barrier for the adoption of biotechnological advances such as gene editing. Within the military, uniformity is used as a mechanism to instil discipline and garner compliance with rules and directions, which is intrinsically tied to the chain of command structure. 146 Making some human enhancement technologies available to some, but not others (e.g. special forces personnel only) may lead to dissent, potentially allowing soldiers to refuse deployment on the basis that they have not been afforded the same protection as others.147

Sign in to recut, update, or save this card.